ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
98,174.99
0.43%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Bioventus Inc (BVS) Quote

Bioventus Inc

Bioventus Inc (BVS)

Bravura Solutions Limited
10.67
0.15
(1.43%)
Closed December 21 4:00PM
Delayed by 15 minutes
10.67
0.02
(0.19%)
After Hours: 5:30PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
10.67
Bid
6.89
Ask
11.58
Volume
538,525
10.27 Day's Range 10.80
3.90 52 Week Range 14.38
Market Cap
865.919M
Previous Close
10.52
Open
10.27
Last Trade
260
@
10.67
(priorref)
Last Trade Time
Financial Volume
$ 5,611,457
VWAP
10.4201
Average Volume (3m)
394,239
Shares Outstanding
81,154,567
Dividend Yield
-
PE Ratio
-5.53
Earnings Per Share (EPS)
-1.93
Revenue
512.35M
Net Profit
-156.23M

About Bioventus Inc

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, in... Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.bioventus.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Bioventus Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BVS. The last closing price for Bioventus was $10.52. Over the last year, Bioventus shares have traded in a share price range of $ 3.90 to $ 14.38.

Bioventus currently has 81,154,567 shares outstanding. The market capitalization of Bioventus is $853.75 million. Bioventus has a price to earnings ratio (PE ratio) of -5.53.

Ask ADVFN Intelligence (AI)

BVS Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 05 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 05 2024
Edgar (US Regulatory)

Bioventus Reports Third Quarter Financial Results

Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* GrowthQ3 Gross Margin Expanded 200 bpsQ3 Cash from Operations of $10.3 million, an Increase of $18.6 million Compared...

November 05 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

November 05 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

November 04 2024
Edgar (US Regulatory)

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will...

October 29 2024
GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933

October 25 2024
Edgar (US Regulatory)

Form 8-K - Current report

October 04 2024
Edgar (US Regulatory)

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has signed...

October 01 2024
GlobeNewswire Inc.

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, senior vice president and...

August 07 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.55-4.9019607843111.2211.5910.3323423610.82709383CS
4-0.88-7.6190476190511.5512.6110.3329790911.4848802CS
12-0.85-7.3784722222211.5214.388.280339423911.88999624CS
264.8683.64888123925.8114.385.285387559.37663206CS
525.4102.4667931695.2714.383.93813358.27225255CS
156-2.41-18.425076452613.0815.570.79994338385.13099669CS
260-4.43-29.337748344415.119.94090.79993870696.41755662CS

BVS - Frequently Asked Questions (FAQ)

What is the current Bioventus share price?
The current share price of Bioventus is $ 10.67
How many Bioventus shares are in issue?
Bioventus has 81,154,567 shares in issue
What is the market cap of Bioventus?
The market capitalisation of Bioventus is USD 853.75M
What is the 1 year trading range for Bioventus share price?
Bioventus has traded in the range of $ 3.90 to $ 14.38 during the past year
What is the PE ratio of Bioventus?
The price to earnings ratio of Bioventus is -5.53
What is the cash to sales ratio of Bioventus?
The cash to sales ratio of Bioventus is 1.69
What is the reporting currency for Bioventus?
Bioventus reports financial results in USD
What is the latest annual turnover for Bioventus?
The latest annual turnover of Bioventus is USD 512.35M
What is the latest annual profit for Bioventus?
The latest annual profit of Bioventus is USD -156.23M
What is the registered address of Bioventus?
The registered address for Bioventus is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Bioventus website address?
The website address for Bioventus is www.bioventus.com
Which industry sector does Bioventus operate in?
Bioventus operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.5M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.63M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.84M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
8.58M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
5.96M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
281.23M

BVS Discussion

View Posts
Monksdream Monksdream 2 months ago
BVS 10Q 11/5
👍️0
Monksdream Monksdream 2 months ago
BVS anew 52 week high
👍️0
Monksdream Monksdream 4 months ago
BVS new 52=high
👍️0
Monksdream Monksdream 4 months ago
BVS new 52 week high
👍️0
Monksdream Monksdream 6 months ago
BVS under $10
👍️0
tw0122 tw0122 7 months ago
Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Source: GlobeNewswire Inc.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

“We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

👍️0
TheFinalCD TheFinalCD 7 months ago
https://twitter.com/MarketCurrents/status/1787801976102924503
👍️0
Monksdream Monksdream 8 months ago
BVS under $5

👍️0

Your Recent History

NASDAQ
BVS
Bioventus
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads